Specific nutritional components are likely to induce intestinal inflammation, which is characterized by increased levels of interleukin 6 (IL6), C-reactive protein (CRP), and tumor necrosis factor-receptor superfamily member 1B (TNFRSF1B) in the circulation and promotes colorectal carcinogenesis. The inflammatory effects of a diet can be estimated based on an empiric dietary inflammatory pattern (EDIP) score, calculated based on intake of 18 foods associated with plasma levels of IL6, CRP, and TNFRSF1B. An inflammatory environment in the colon (based on increased levels of IL6, CRP, and TNFRSF1B in peripheral blood) contributes to impairment of the mucosal barrier and altered immune cell responses, affecting the composition of the intestinal microbiota. Colonization by Fusobacterium nucleatum has been associated with the presence and features of colorectal adenocarcinoma. We investigated the association between diets that promote inflammation (based on EDIP score) and colorectal cancer subtypes classified by level of F nucleatum in the tumor microenvironment.
Follow-up Study (through January 31, 2012). Participants in both cohorts reported diagnoses of rectal or colon cancer in biennial questionnaires; deaths from unreported colorectal cancer cases were identified through the National Death Index and next of kin. Colorectal tumor tissues were collected from hospitals where the patients underwent tumor resection and F nucleatum DNA was quantified by a polymerase chain reaction assay. We used multivariable duplicationmethod Cox proportional hazard regression to assess the associations of EDIP scores with risks of colorectal cancer subclassified by F nucleatum status.
RESULTS:
During 28 years of follow-up evaluation of 124,433 participants, we documented 951 incident cases of colorectal carcinoma with tissue F nucleatum data. Higher EDIP scores were associated with increased risk of F nucleatum-positive colorectal tumors (P trend [ .03); for subjects in the highest vs lowest EDIP score tertiles, the hazard ratio for F nucleatum-positive colorectal tumors was 1.63 (95% CI, 1.03-2.58). EDIP scores did not associate with F nucleatum-negative tumors (P trend [ .44 ). High EDIP scores associated with proximal F nucleatum-positive colorectal tumors but not with proximal F nucleatum-negative colorectal tumors (P heterogeneity [ .003).
CONCLUSIONS:
Diets that may promote intestinal inflammation, based on EDIP score, are associated with increased risk of F nucleatum-positive colorectal carcinomas, but not carcinomas that do not contain these bacteria. These findings indicate that diet-induced intestinal inflammation alters the gut microbiome to contribute to colorectal carcinogenesis; nutritional interventions might be used in precision medicine and cancer prevention.
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C hronic inflammation is a well-established etiologic factor for colorectal carcinoma. 1, 2 We have shown that the inflammatory diets that could induce systemic and intestinal inflammation were associated with a higher risk of colorectal cancer. 3 Although the underlying mechanisms remain unclear, recent evidence has indicated that the cancer-promoting effect of diet-related inflammation can be enhanced by certain bacterial species in the intestinal microbiota. 1, 2, 4 Intestinal inflammation decreases the production of protective mucins and antimicrobial peptides, 5 which may facilitate the adherence of bacteria to colonic mucosa. The impaired mucosal barrier function enables bacteria to interact more readily with the epithelium, resulting in colonization of bacteria within colonic mucosa and increased exposures of intestinal cells to bacterial mutagenic metabolites.
Some gut microbiota including Fusobacterium nucleatum, a potentiator for colorectal cancer, may contribute to carcinogenesis through their influence on expression of transcription factors, oncogenes, and inflammatory genes, 1, 2, [6] [7] [8] and recruitment of monocytes and myeloidderived suppressor cells to generate an inflammatory microenvironment. 7, 9 Studies have shown the enrichment of F nucleatum in colorectal tumor tissues compared with adjacent normal tissues. [10] [11] [12] [13] The presence of detectable F nucleatum in tumor tissues has been associated with proximal tumor location, serrated neoplasia pathway, consensus molecular subtypes, microsatellite instability (MSI), and high-level macrophage and low-level CD3 þ T-cell infiltrate in tumor. 10, [14] [15] [16] [17] [18] In addition, the existence of F nucleatum within tumor tissues has been reported to contribute to disease progression and chemoresistance in patients with colorectal cancer. 19, 20 Given the role of F nucleatum in shaping the tumor-promoting inflammatory environment and the enrichment of F nucleatum in intestinal carcinomas, we hypothesized that the association of inflammatory diets (diets that promote inflammation) with colorectal cancer risk might be stronger for tumors containing F nucleatum than for tumors without detectable F nucleatum.
To test this hypothesis, we used a molecular pathologic epidemiology database within 2 prospective cohort studies (the Nurses' Health Study [NHS] and the Health Professionals Follow-up Study [HPFS] ) with long-term biennial questionnaire data and colorectal tumor tissues available for molecular and microbial analyses. We prospectively examined updated information on inflammatory diet intakes in relation to incidence of colorectal cancer subtypes classified by F nucleatum in tumor tissues.
Methods

Study Population
The NHS enrolled 121,700 registered female nurses in the United States aged 30 to 55 years at baseline in 1976, and the HPFS recruited 51,529 male health professionals aged 40 to 75 years at baseline in 1986 (Figure 1) . 21 In both cohorts, follow-up questionnaires were administered at baseline and every 2 years thereafter to collect and update lifestyle and health-related information. Validated food frequency questionnaires were sent every 4 years to update dietary information. We followed up participants from baseline questionnaire return through June 1, 2012, in the NHS or through January 31, 2012, in the HPFS. Written consent was obtained from each participant. This study was approved by Human Subjects Committees at Harvard T.H. Chan School of Public Health and Brigham and Women's Hospital. This study was reported according to the Strengthening the Reporting of Observational Studies in Epidemiology statement. 22 
Acquisition of Colorectal Cancer Cases
In both cohorts, participants reported a diagnosis of colon or rectal cancer in biennial questionnaires. Deaths from unreported colorectal cancer cases were identified through the National Death Index and next of kin. All colorectal carcinoma diagnoses were verified through centralized histopathologic examination by the study pathologist (S.O.). We included both colon and rectal carcinomas based on the colorectal continuum model.
16,23
Assessment of Diets and Other Covariates
The inflammatory effects of diets were estimated based on the empirical dietary inflammatory pattern (EDIP) score, which is the sum of weighted intake scores of 18 foods (processed meat, red meat, organ meat, fish, vegetables other than green leafy vegetables and dark yellow vegetables, refined grains, high-energy beverages, low-energy beverages, tomatoes, beer, wine, tea, coffee, dark yellow vegetables, green leafy vegetables, snacks, fruit juice, and pizza) constructed to predict plasma levels of interleukin 6 (IL6), C-reactive protein, and tumor necrosis factor-receptor superfamily member 1B, (TNFRSF1B, or so-called tumor necrosis factor alpha-receptor 2). 24 The higher scores represent inflammatory diets and lower scores indicate anti-inflammatory diets. 24 The EDIP scores were calculated for each participant at each questionnaire cycle. We set 1984 as the study baseline for the NHS, and 1986 for the HPFS. The cumulative average EDIP scores were computed further by averaging all prior EDIP scores up to each questionnaire cycle. Participants were categorized into tertiles using cohort-specific cut-off points of the cumulative average of EDIP scores. Information on lifestyles and medication was assessed using biennial questionnaires in both cohorts as previously described. 21, 25 Analyses of F nucleatum and Other Tumor Characteristics
Archival formalin-fixed, paraffin-embedded tumor tissue blocks of confirmed colorectal cancer cases were collected from hospitals where the patients underwent tumor resection. DNA was extracted from colorectal cancer tissue using the QIAamp DNA Formalin-Fixed, Paraffin-Embedded Tissue Kit (Qiagen, Valencia, CA). The amount of tissue F nucleatum DNA was measured by a quantitative polymerase chain reaction assay and normalized with the reference gene SLCO2A1 as previously described. 13, 15 Cases with detectable F nucleatum DNA were categorized as positive, otherwise as negative. Cases with positive F nucleatum were categorized further as low or high relative to the median cut-off point of F nucleatum DNA quantities among F nucleatum-positive cases. 26 MSI and PTGS2 (prostaglandin-endoperoxide synthase 2, or so-called cyclooxygenase-2) expression in tumors were assessed as previously described. 25 
Statistical Analysis
Participants who died of causes other than colorectal cancer and those who were free of colorectal cancer at the end of the follow-up evaluation were censored. In addition, colorectal cancer cases with unknown F nucleatum status were censored at the time of diagnosis. For each participant, we calculated follow-up time (in months) from the date of the questionnaire return at the study baseline until the date of death, colorectal cancer diagnosis, or end of follow-up evaluation, whichever came first. We used duplication-method Cox proportional cause-specific hazard regression for competing risks data 27 to assess the associations between time-varying EDIP scores and risks of colorectal cancer subtypes classified by F nucleatum status in tumors. Testing for trend across tertiles of EDIP scores was performed using the median value of each tertile group in the Cox regression models. To examine the heterogeneity in associations with various colorectal cancer subtypes, we used the likelihood ratio test by comparing the model in which the association with EDIP was allowed to vary by tumor subtypes to a model in which a common association was assumed across tumor subtypes. The multivariable models were primarily adjusted for smoking status, family history of colorectal cancer, endoscopy status, physical activity levels, total calorie intake, alcohol consumption, current multivitamin use, and regular aspirin use. Considering overweight/obesity may act as a mediator and a confounder, 24 body mass index was added further into the multivariable models. Given that not all confirmed cases were available for detection of F nucleatum, inverse probability weighting was used to reduce bias from potentially varied F nucleatum data availability. This was achieved by calculating the cohort-specific predictive probability of observing F nucleatum data for each case using multivariable logistic regression as previously described.
28 SAS 9.4 (SAS Institute, Inc, Cary, NC) was used for all statistical analyses. All statistical tests were 2-sided.
Results
Characteristics of Study Participants
The exclusion for baseline diet data, cancer history, polyposis syndrome, inflammatory bowel disease, and implausible energy intake led to inclusion of a total of 124,433 participants in the final analysis. During 28 years of follow-up evaluation with 2,998,587 personyears, we documented 951 colorectal cancer cases with available F nucleatum data ( Figure 1 ). Participants reporting high inflammatory diet intake were more likely to have a higher body mass index and energy intake, but lower amounts of pack-years of cigarette smoking, physical activity, multivitamin intake, and alcohol intake ( Table 1) . We did not observe evidence of a substantial violation of the proportionality of hazards assumption on the basis of interaction terms between EDIP scores and follow-up time (P ¼ .42), however, we stratified all analyses by stratified by age (in months), year of questionnaire return, and sex (cohort). Except for the colorectal cancer subtype with negative F nucleatum in tumors (P heterogeneity ¼ .002), we did not observe significant heterogeneity between cohorts for the associations of EDIP scores with risks of other colorectal cancer subtypes. To increase statistical power, the NHS and the HPFS were combined to perform pooled analyses stratified by sex (cohort), age in months, and calendar year of the questionnaire cycle to estimate the association between inflammatory diet and risk of colorectal cancer subclassified by F nucleatum.
Empirical Dietary Inflammatory Pattern Scores and Colorectal Cancer Risk by F nucleatum
High EDIP (highest tertile) scores were associated with a higher risk of F nucleatum-positive colorectal tumor subtype (P trend ¼ .03; highest vs lowest EDIP score tertile: multivariable-adjusted HR, 1.63; 95% CI, 1.03-2.58), but not with risk of F nucleatum-negative tumors (P trend ¼ .44); although the test for heterogeneity did not reach statistical significance (P heterogeneity ¼ .07) ( Table 2) . We conducted an analysis stratified by tumor location because a high amount of F nucleatum in colorectal carcinoma tissues has been associated with proximal tumor location. 10, 16 Compared with distal colon and rectal cancers, the differential associations of EDIP scores with the tumor subtypes classified by tissue F nucleatum became more pronounced in proximal colon cancer (P heterogeneity ¼ .003) ( Table 3) , in which high EDIP scores were associated with a higher risk of F nucleatum-positive tumor subtype (P trend ¼ .003; highest vs lowest EDIP score tertile: multivariable-adjusted HR, 2.61; 95% CI, 1.35-5.05), but not with risk of F nucleatum-negative tumor subtype (P trend ¼ .84). Sensitivity analyses using Cox proportional cause-specific hazards regression weighted by inverse probability of F nucleatum data availability generated similar results to those of the primary analyses (Supplementary Table 1 ). Further analyses in each cohort showed that the associations of EDIP scores with colorectal cancer incidence tended to be stronger for F nucleatum-positive tumor subtype than for F nucleatum-negative tumor subtype in each of NHS and HPFS (Supplementary Table 2 ).
Because of the reported association of MSI status and PTGS2 expression with F nucleatum in colorectal tumors, 10, 26, 29 we further examined whether the differential association between inflammatory diets and risk of colorectal cancer subtypes classified by tumor F nucleatum status varied according to tumor MSI status or PTGS2 expression levels. We found that the differential association appeared to be generally consistent irrespective of tumor MSI or PTGS2 status, although statistical power was limited in the subset analyses (Table 4) .
Considering the protective role of prudent dietary pattern against the F nucleatum-positive colorectal tumor subtype, 30 and the very weak negative correlation between EDIP scores and prudent dietary pattern scores (r ¼ -0.04; P < .0001), we further tested whether the distinct association of EDIP scores with risk of colorectal cancer subclassified by tumor F nucleatum status differed according to prudent dietary patterns. We found that the differential association was maintained in the low prudent dietary pattern group, but not in the high prudent dietary pattern group (Supplementary Table 3 ).
Discussion
The current study suggests that diets that may promote inflammation (measured by EDIP scores) might be associated with a higher risk of F nucleatum-positive colorectal tumors but not the risk of F nucleatumnegative colorectal tumors. The positive association of EDIP scores with risk of F nucleatum-positive tumors seemed much stronger for proximal colon cancer than for distal colorectal cancer. This was a population-based study to assess a potential role of intestinal bacteria in mediating the increased colorectal cancer risk associated with diet-induced inflammation. A better understanding of the role of interactions between inflammatory diets and intestinal microbiota in colorectal carcinogenesis can help us design improved dietary prevention strategies against carcinoma. 31, 32 Inflammation is recognized as a necessary trigger for colorectal cancer, but inflammation alone may be not enough to promote tumorigenesis. Complex interactions among the gut microbiota, inflammation, environmental exposures, and host genetics are needed for colorectal carcinogenesis.
2 Dietary components and patterns play roles in regulating intestinal homeostasis by altering microbial composition and diversity. Inflammatory diets may contribute to the development of dysbiosis by decreasing the amount of beneficial microorganisms and promoting the growth of harmful bacteria. 33 During progression of local intestinal inflammation triggered by inflammatory diets, the epithelial barriers separating the microbiota from immune cells in the lamina propria begin to break down, which facilitates translocation of intestinal microbiota and exposure of immunogenic microbial components to both epithelial cells and antigen-presenting cells. 1, 4, 34 These immunogenic microbial components, such as bacterial membrane vesicles and enterotoxin, may cause mutations in DNA repair genes and/or tumor-suppressor genes, which likely would result in expedited initiation of hyperplasia and polyps. 1, 2, 6 Accumulating evidence has indicated that high intake of fat and sugar could create an inflammatory environment in the gut characterized by an overgrowth of inflammatory bacteria and a decrease of beneficial bacteria, and subsequently aggravate tumorigenesis through activating TGFB1/SMAD3 and NF-kB signaling pathways; whereas anti-inflammatory diets could increase the abundance of beneficial bacteria and suppress NOTE. Cox proportional cause-specific hazard regression for competing-risks data was used to compute HRs and 95% CIs. All analyses were stratified by age (in months), year of questionnaire return, and sex. HR, hazard ratio; T1, tertile 1; T2, tertile 2; T3, tertile 3.
a Linear trend test using the median value of each category. b The likelihood ratio test was used for the heterogeneity of the association between the EDIP scores and colorectal cancer risk according to tumor F nucleatum status (negative vs positive-low vs positive-high). tumorigenesis through activating chloride channels. 35, 36 The presence of F nucleatum may represent an immunecompromised intestinal environment. 37 F nucleatum adheres to epithelial cells by binding its own adhesin Fusobacterium adhesin A, a virulence factor identified in F nucleatum, to CDH1 (E-cadherin) on epithelial cells. Fusobacterium adhesin A modulates CDH1 (E-cadherin) and activates CTNNB1 (b-catenin) signaling, leading to increased expression of transcription factors, inflammatory genes, and oncogenes. 38 F nucleatum has been reported to be associated with an inflammatory microenvironment, which is conducive to colorectal neoplasia progression. 9 Furthermore, F nucleatum could accelerate the progression of tumors by inhibiting Tcell-mediated immune responses against colorectal tumors.
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The characteristics of the microbiome differ by regions of the gastrointestinal tract given the varying pH, transit time, nutrient availability, exposure to oxygen, host secretions, mucosal surface, and immune system throughout.
1,2 Previous evidence has indicated that F nucleatum often is enriched in proximal colon tumors when compared with distal colon and rectal tumors. 26 Compared with patients with left-sided colon tumors, patients with right-sided tumors had much higher rates of polymicrobial bacterial biofilms on tumor tissues and tumor-free mucosa far from the tumors. Bacterial biofilms have been correlated with enhanced IL6 and STAT3 activation in epithelial cells, and therefore increased proliferation of these cells. 39 This may explain the anatomic difference in associations between inflammatory diets and colorectal cancer risk according to the amount of F nucleatum in tumor tissues.
The influence of tumor MSI status and PTGS2 expression should be analyzed in the current study of inflammatory diets and risk of colorectal cancer according to the amount of tumor F nucleatum, provided that F nucleatum, provided that F nucleatum is enriched in MSI-high tumors 26 and that the PTGS2 enzyme produces inflammatory mediators and is implicated in colorectal carcinogenesis. 40 In the current study, we found that the differential association between EDIP scores and colorectal cancer risk according to the amount of tumor F nucleatum appeared to be generally .54
NOTE. Cox proportional cause-specific hazards regression for competing-risks data was used to compute HRs and 95% CIs. All analyses were stratified by age (in months), year of questionnaire return, and sex. HR, hazard ratio; T1, tertile 1; T2, tertile 2; T3, tertile 3. consistent in tumors with different MSI or PTGS2 status, further supporting a distinct role of F nucleatum in mediating the association between inflammatory diets and colorectal cancer. Our current study had limitations. First, despite the large sample size from the 2 cohorts, the number of cases with detectable tumor F nucleatum was relatively small. Second, EDIP assessments were based on self-reported food frequency questionnaires. Although measurement errors exist, validation studies have shown reasonable validity and reproducibility. 24 Third, we could not obtain tumor tissues from every confirmed colorectal cancer .02
NOTE. Cox proportional cause-specific hazards regression for competing-risks data was used to compute HRs and 95% CIs. All analyses were stratified by age (in months), year of questionnaire return, and sex. HR, hazard ratio; MSI, microsatellite instability; T1, tertile 1; T2, tertile 2; T3, tertile 3. case. However, the consistent results from the primary analyses and sensitivity analyses imply any selection bias caused by unavailability of tumor tissues was unlikely to be substantial. Fourth, more than 90% of participants in our study were non-Hispanic whites; hence, the generalizability of our findings to other population groups remains to be assessed. There were several advantages of our study. First, the long-term prospective collection of data on dietary intake and other potential confounders enabled us to estimate cumulative averages of EDIP scores and all other quantitative factors with relatively small measurement errors within individuals. Second, our molecular pathologic epidemiology database enabled us to estimate the amount of tumor F nucleatum in almost 1000 confirmed colorectal cases, which is rarely achieved in other epidemiologic studies. Third, the molecular pathologic epidemiology analysis method 27 enabled us to assess the differential association of inflammatory diets with incidence of colorectal cancer subtypes classified by F nucleatum in tumor tissues. Hence, we can evaluate the combined role of diet and the microbiome in cancer occurrence.
In summary, our current study has shown that inflammatory diets are associated with a higher risk of F nucleatum-positive colorectal tumors, but not with the risk of F nucleatum-negative tumors. This differential association between inflammatory diets and colorectal cancer risk according to the amount of tumor F nucleatum appeared to be stronger in proximal colon cancer than in distal colon and rectal cancer. Our finding suggests potential interactive roles of diet-related inflammation and the gut microbiota in colorectal tumorigenesis. Although further confirmation of our findings is needed, we would like to recommend an overall anti-inflammatory dietary pattern, including high intake of green leafy vegetables, dark-yellow vegetables, coffee, and tea, and low consumption of red meat, processed meat, refined grain, and sugary beverages, to reduce the risk of developing colorectal cancer. Notably, integrated analyses of environment, microbiome, tumor, and immunity are increasingly important. 1, 2, 31, 32, 40 Further studies also are warranted to determine the potential utility of characterization of F nucleatum in colonic tumor or stool as a biomarker for personalized dietary interventions. .003
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NOTE. Cox proportional cause-specific hazards regression weighted by the inverse probability of availability of tumor F nucleatum status for competing-risks data was used to compute HRs and 95% CIs. All analyses were stratified by age (in months), year of questionnaire return, and sex. HR, hazard ratio; T1, tertile 1; T2, tertile 2; T3, tertile 3.
a Linear trend test using the median value of each category. b The Wald test was used for the heterogeneity of the association between the EDIP scores and colorectal cancer risk according to tumor F nucleatum status (negative vs positive). Supplementary NOTE. Cox proportional cause-specific hazards regression for competing-risks data was used to compute HRs and 95% CIs. All analyses were stratified by age (in months), year of questionnaire return, and sex. HR, hazard ratio; T1, tertile 1; T2, tertile 2; T3, tertile 3. c The likelihood ratio test was used for the heterogeneity of the association between the EDIP scores and colorectal cancer risk according to tumor F nucleatum status (negative vs positive).
